Indonesian Journal of Cancer Chemoprevention.
February 2010 ISSN: 2088Ae0197 e-ISSN: 2355-8989 Platinum Metal Complexes of Carbaboranylphophines:
Potential Anti Cancer Agents Ilham Maulana1,*.
Peter Loennecke2.
Evamarie Hey-Hawkins2 Department of Chemistry.
Faculty of Mathematics and Natural Science.
Syiah Kuala University.
Banda Aceh.
Indonesia.
Email: ilham.
maulana@gmail.
Institute of Inorganic Chemistry.
Leipzig University.
Leipzig.
Germany Abstract Polyhedral heteroboranes in particular dicarba-closo-dodecaboranes.
and their organic derivatives have been the subject of intense research for over 40 years due to their unique chemical and physical properties.
The initial attraction to dicarba-closododecaboranes.
In the medicinal chemistry research, was a result of their high boron content and stability to catabolism, which are important criteria for cancer therapy, such as BNCT .
oron neutron capture therap.
The coordination compounds of the platinum group metals have also received large interest for their potential application as chemotherapeutic agents, since cis-diamminedichloroplatinum(II), cisplatin, has been reported to have capability as tumor inhibitor.
Hence, applications can be envisioned for related cis platinum complexes.
Complex of cis-rac-[PtCl2.
,2-(PRC.
2C2B10H.
] (R=Ph, tBu.
NEt2.
NPh.
have been synthesized by employing known carbaborane based phosphine ligands of clorophoshino-closo-dodecaborane , with complex of cis-[PtCl2(COD)] (COD = 1,5cyclooctadien.
in an N2-atmosphere.
The obtained complexes possess expected structure configuration, namely cis-rac.
The characterization of the complex has been carried out using 1H, 31P, 13C and 11B-NMR (Nuclear Magnetic Resonanc.
X-ray of single crystals, elemental analysis.
IR .
nfra re.
and mass spectroscopy (MS).
The 31P.
H} NMR spectra of all the platinum complexes distinctly show the typical platinum satellites which are attributed to 31P195Pt-coupling, in which the 31P.
H} NMR spectrum exhibits three lines with an intensity ratio of 1:4:1.
The structure of the platinum complexes consists of a slightly distorted square-planar coordination sphere, in which the platinum atom is bonded to two chlorides and two phosphorus atoms of the chelating carbaboranylphosphine.
Thus the platinum atoms exhibit the coordination number four, which is preferred in platinum(II) complexes.
Keywords: Platinum complexes, phosphine ligand, carbaborane INTRODUCTION Polyhedral heteroboranes in particular dicarba-closo-dodecaboranes.
and their organic derivatives have been the subject of intense research for over 40 years due to their unique chemical and physical properties [Valliant, et al.
Williams, 1992.
Leites, 1.
Thus, these compounds have been employed as catalysts [Yinghuai, et al.
, 2004.
Larsen, et al.
, 2000.
Teixidor, et al.
, 1996.
Longato and Bresadola, 1.
, as doping reagents in semiconductor materials [Bakun, et al.
USSR Patent, 402.
, and also in medical areas [Hawthorne, 1993.
Soloway, 1.
In the medicinal chemistry research, the initial attraction to dicarba-closododecaboranes.
was a result of their high boron content and stability to catabolism, which are important criteria for BNCT .
oron neutron capture therap.
BNCT is based on the B.
A)7Li reaction, which occurs when boron10, which has a large capture cross section relative to the more abundant endogenous nuclei .
H, 12C.
P, 14N), is exposed to thermal neutrons.
The reaction releases high linear-energy-transfer radiation particles consisting of -particles .
and lithium atoms .
[Locher, 1.
These particles cause direct DNA damage and tumor cell *Corresponding author e-mail : ilham.
maulana@gmail.
Maulana, et al.
, 2010
Indones.
Cancer Chemoprevent.
, 1.
, 1-11
-4567-
The coordination compounds of the platinum group metals have also received large interest for their potential application as cisdiamminedichloroplatinum (II), cisplatin [Peyrone, , 1.
, has been reported to have capability as tumor inhibitor [Rosenberg, et al.
, 1.
Cisplatin is one of the most commonly used anti-cancer drugs today.
It is used mainly in combination chemotherapy and effective against testicular carcinomas [Rozencweig, et al.
, 1.
The excellent activity of cisplatin in testicular carcinomas has demonstrated the possibility to find new drugs in the area of inorganic chemistry that are capable of curing specific types of tumors.
Numerous other metal compounds containing platinum, other platinum group metals, and even non-platinum metals were then shown to be effective against human tumors and tumors in animals [Kopf-Maier, 1.
Hence, applications carbaboranylphosphines and transition metal complexes thereof.
In connection with our interest, related to the above mentioned areas, this paper describes the synthesis and the coordination properties of bidentate chiral tertiary phosphinodicarba-closododecaborane.
ligands to form cis-platinum A range of ligands with different electronic and steric properties was synthesized by varying the substituents on the phosphorus atoms.
Variation of these substituents can give significant changes in the electron-donor or -acceptor properties of the phosphines and in the steric demand of the phosphines as well.
The resulting phosphines were employed as ligands in complexes of platinum metal.
METHODS
All the reactions were carried out in an atmosphere of dry nitrogen using standard Schlenk or vacuum line techniques.
The solvents were purified .
iethyl ether.
THF, toluene: reflux over Na/benzophenone.
CH2Cl2, n-hexane.
MeOH:
reflux over powdered CaH.
and distilled under The glassware was oven-dried for several hours, assembled while hot, and cooled in a stream of dry nitrogen gas.
The infrared spectra were recorded on a Perkin-Elmer System 2000 FT-IR spectrometer scanning between 400 and 4000 cm-1 using KBr disks.
The 1H, 13C, 31P and 11B NMR spectra were recorded on an AVANCE DRX 400 spectrometer (Bruke.
The chemical shifts for the H and 13C NMR spectra are reported in parts per million .
13 MHz and 100.
6 MHz with tetramethylsilane as standard.
The chemical shifts for the 31P NMR spectra are reported in parts per million .
97 MHz .
ith 85 % H3PO4 external standar.
and chemical shifts for 11B NMR spectra are in parts per million .
at 38 MHz with BF3 (OEt.
as external standard.
The mass spectra were recorded on an Ltd.
ZABHSQ-VG Analytical Manchester Spectrometer (FAB mass spectr.
and on an FT-ICR-MS Bruker-Daltonics ESI mass spectrometer (APEX II, 7 Tesl.
The elemental analyses were recorded on a VARIO EL (Heraeu.
The melting points were determined in sealed capillaries and are The products of the catalytic reactions were determined by GC analysis using an AGILENT 6890 gas chromatograph with split/splitless injector and a CP-CHIRASIL-LVAL column.
The crystallographic data were collected on a Siemens CCD (SMART) diffractometer .
ompounds 5 and .
and a StoeIPDS imaging plate diffractometer .
The empirical absorption correction was performed with SADABS [Sheldrick, 1.
(Siemens CCD diffractomete.
and the numerical absorption correction using XRED (Stoe-IPDS The structures were solved by direct methods (SHELXTL PLUS) [SHELXTL PLUS.
SHELXS, 1.
The compound ortho-closo-carbaborane was donated by INEOS (A.
Nesmeyanov Institute of Organoelement Compounds Russian Academy of Sciences.
Moscow.
Russian Federatio.
The chemicals n-butyllithium, dichlorophenylphosphine.
PCl3.
N,N-diethylamin, tert-butylchlorid.
N,N-diphenylamin.
COD .
,5cyclooctadien.
were used as purchased.
H2[PtCl.
A 6 H2O was generously donated by Umicore.
BuPCl2 [Imori, 1.
P(NEt.
Cl2 [Perich and Johns, 1.
P(NPh.
Cl2 [Falius and Babin, 1.
, [PtCl2(COD)] [Cotton, 1972.
Brauer.
, were prepared according to the literature.
Preparation of the Known Compounds rac-1,2-Bis.
ert-butylchlorophosphin.
-1,2dicarba-closo-dodecaborane.
[Sterzik et al.
rac-1,2-bis.
-1,2dicarba-closo-dodecaborane.
[Balema et al.
Alexander and Schroeder, 1.
, rac-1,2Bis(N,N-diethylaminochlorophosphin.
-1,2dicarba-closo-dodecaborane.
, and rac-1,2Bis(N,N-diphenylaminochlorophosphin.
-1,2dicarba-closo-dodecaborane.
[Stadlbauer et , 2.
were prepared according to the literature and obtained in good yield.
Maulana, et al.
, 2010
Indones.
Cancer Chemoprevent.
, 1.
, 1-11
-4567-
Synthesis of cis-rac-AuPtCl2A1,2(PtBuC.
2C2B10H10AAy .
A mixture of 0.
2 g .
53 mmo.
AuPtCl2(COD)Ay (COD = 1,5-cyclooctadien.
, 0.
53 mmo.
1 and 50 ml toluene was refluxed for 2 h.
The mixture was then concentrated to yield a white precipitate .
Crystallization from toluene solution gave colorless crystals of 5.
Yield:
25 g .
%).
: 280 CC .
ecomposes, turns Found: C 18.
H 4.
47 %.
Calc.
C10H28B10Cl4P2Pt: C 18.
H 4.
31 %.
FAB-MS,
m/z: 619 .
M - C.
, 584 .
M - 2C.
Calc.
for C10H28B10Cl4P2Pt: M = 655.
1H NMR
(CDCl3/TMS, pp.
: 3.
75 - 1.
, vbr, 10H.
C2B10H.
, 1.
, 3JPH = 22 Hz, 18H.
CH.
NMR (CDCl3, pp.
: 122.
JPPt = 3873 H.
NMR (CDCl3/TMS, pp.
: 85.
t, 2JCPt = 102.
Hz, 1JPC = 28.
1 Hz.
Ccluster-P), 50.
, 2JCPt = 54.
Hz, 1JPC = 40.
1 Hz, 3JPC = 7.
9 Hz.
CMe.
, 28.
JCH = 130.
0 Hz, 2JPC = 4.
5 Hz.
CH.
11B NMR
(CDCl3, pp.
: 0.
, 1JBH = 151 Hz, 2B.
C2B10H.
, -3.
, 1JBH = 154 Hz, 2B.
C2B10H.
, 44 .
, vbr, 6B.
C2B10H.
IR (KBr, cm-.
3015m, 2995m, 2961m, 2926m, 2868m (CH).
2678m, 2666s, 2639s, 2595s, 2576s, 2564s (BH).
1955w, 1626w, 1471s, 1459s, 1433m, 1401s, 1368s, 1261m, 1165s, 1070s, 1017s, 976w, 930m, 902w, 884w, 835m, 797s, 772m, 749s, 733s, 682w, 665m, 629s, 570s, 542s, 495s, 458m, 448m.
Synthesis of cis-rac-AuPtCl2A1,2(PPhC.
2C2B10H10AAy .
A mixture of 0.
2 g .
53 mmo.
AuPtCl2(COD)Ay, 0.
23 g .
53 mmo.
2 and 50 ml toluene was refluxed for 2 h.
The mixture was then concentrated to yield 0.
31 g of a white precipitate.
Crystallization from toluene solution gave colorless crystals of 6.
Yield: 0.
31 g .
%).
320 CC .
ecomposes, turns brow.
Found: C H 2.
06 %.
Calc.
for C14H20B10Cl4P2Pt: C H 2.
90 %.
FAB-MS, m/z: 659 .
M C.
, 624 .
M - 2C.
M - 3C.
Calc.
for C14H20B10Cl4P2Pt: M = 695.
1H NMR
(C6D6/TMS, pp.
: 7.
70 - 6.
, 10H.
, 7.
everal m.
Ph in C7H.
, 3.
73 - 1.
, vbr, 10H.
C2B10H.
, 2.
, 3H.
CH3 in C7H.
NMR (C6D6, pp.
: 97.
JPPt = 4038 H.
NMR (C6D6, pp.
: -1.
, 1JBH = 143 Hz, 4B.
C2B10H.
, -10.
, 1JBH = 142 Hz, 4B.
C2B10H.
, 6 .
, 1JBH = 168 Hz, 2B.
C2B10H.
IR (KBr, cm-.
: 3082w, 3055m, 3022m, 2959w, 2917w (CH).
2614, 2582 (BH).
2191w, 1965w, 1894w, 1809w (P.
1603w, 1580m, 1494m, 1475m, 1436s, 1384w, 1336w, 1310s, 1283w, 1261m, 1186m, 1160m, 1097s, 1076s, 1025m, 997m, 981m, 937m, 900m, 852s, 798s, 732s, 713s, 695s, 684s, 630s, 616s, 575s, 553s, 514s, 485s, 472s.
The low solubility of 6 prevents measurement of the 13C NMR spectrum.
Synthesis cis-rac-AuPtCl2A1,2{P(NEt.
2C2B10H10AAy .
A mixture of 0.
14 g .
37 mmo.
AuPtCl2(COD)Ay, 0.
16 g .
37 mmo.
3 and 50 ml toluene was refluxed for 10 h.
The mixture was then concentrated to obtain 0.
18 g of a white Crystallization from toluene solution gave colorless crystals of 7.
Yield: 0.
18 g .
%).
: 230 CC .
ecomposes, turns blac.
Found: C H 4.
N 3.
43 %.
Calc.
C10H30B10Cl4N2P2Pt A 0.
5C7H8 : C 22.
H 4.
N 3.
83 %.
FAB-MS, m/z: 649 .
M - C.
, 614 .
M - 2C.
, 577 .
M - 3C.
, 542 .
M - 4C.
Calc.
for C10H30B10Cl4N2P2Pt: M = 1H NMR (CDCl3/TMS, pp.
: 3.
65 and 42 .
, br, 8H.
CH.
, 3.
55 - 1.
, vbr, 10H.
C2B10H.
, 1.
, 3JHH = 8 Hz, 12H.
CH.
NMR (CDCl3, pp.
: 98.
JPPt = 4663 H.
NMR (CDCl3/TMS, pp.
: 129.
1 - 124.
everal m.
C7H.
, 90.
t, 1JPC = 25.
2 Hz, 2JPC = 25.
2 Hz.
JCPt = 168.
8 Hz.
Ccluster-P), 44.
, vbr.
CH.
, 5 .
, 1JCH = 138.
5 H.
, 1JCH = 126.
7 Hz.
CH.
11B NMR (CDCl3, pp.
: -2.
, 1JBH = 142 Hz, 4B.
C2B10H.
, -10.
, vbr, 4B.
C2B10H.
, 14.
, vbr, 2B.
C2B10H.
IR (KBr, cm-.
2981s, 2937s, 2894s (CH).
2621s, 2582s (BH).
1860w, 1706w, 1626w, 1494w, 1462m, 1444m, 1382s, 1363m, 1343m, 1289m, 1262w, 1201s, 1151s, 1100s, 1076s, 1057s, 1020s, 962s, 925w, 847s, 799s, 760w, 740m, 688m, 671m, 628s, 579s, 549s, 495s, 459m, 417w.
Synthesis of cis-rac-AuPtCl2A1,2{P(NPh.
2C2B10H10AAy .
A mixture of 0.
13 g .
35 mmo.
AuPtCl2(COD)Ay, 0.
21 g .
35 mmo.
4 and 35 ml toluene was refluxed for 105 h.
The mixture was then filtrated and concentrated to obtain 0.
043 g of a white precipitate of 8.
Yield: 0.
043 g .
%).
NMR (CDCl3/TMS, pp.
: 7.
76 - 7.
, br, 20H.
, 3.
56 - 1.
, vbr, 10H.
C2B10H.
31P NMR
(CDCl3, pp.
: 94.
JPPt = 4895 H.
11B NMR
(CDCl3, pp.
: -2.
, vbr, 4B.
C2B10H.
, -11.
, vbr, 6B.
C2B10H.
The amount of substance obtained was insufficient for other characterization Maulana, et al.
, 2010
Indones.
Cancer Chemoprevent.
, 1.
, 1-11
-4567-
RESULTS AND DISCUSSION
The preparation of a platinum complex with a non-chiral carbaboranylphosphine ligand, cis[PtCl2.
,2-(PiPr.
2-1,2-C2B10H.
] reported [Paavola et al.
, 2.
, in which [PtCl2(COD)] (COD = 1,5-cyclooctadien.
was used as starting material.
Several platinum bisphosphines of ortho-carbaborane were prepared cis-[PtCl2.
-PPh2-2P(NMe.
2(C2B10H.
}], cis-[PtCl2.
-PPh2-2P(NMe.
F(C2B10H.
}], cis-[PtCl2.
-P(NMe.
F-2P(NMe.
2(C2B10H.
}], and cis-[PtCl2.
-PPh2-2PF2(C2B10H.
}] [Hill et al.
, 1.
However, carbaboranylphosphine ligands were not yet Synthesis and Spectroscopic Properties of Platinum Complexes with Carbaboranylphosphine Ligands The platinum complexes cis-rac-AuPtCl2A1,2(PRC.
2C2B10H10AAy (R = tBu .
Ph .
NEt2 .
NPh2 .
were synthesized employing a similar procedure as for cis-[PtCl2.
,2-(PiPr.
2-1,2C2B10H.
], in which [PtCl2(COD)] was stirred in a boiling toluene solution with a suitable chiral carbaboranylphosphine ligand .
Except cis-rac-AuPtCl2A1,2{P(NPh.
2C2B10H10AAy .
, all other platinum complexes were obtained in good yield .
-93 %).
Complex 8 could only be obtained in 14 % yield.
The signal of the free ligand was observed in the P NMR spectrum of the reaction mixture even after refluxing for more than 100 h, while the amount of the side products increased.
The steric demand of the bulkier substituent.
NPh2, is presumably responsible for hampering the Compounds 5 - 8 were obtained as air- and water-stable solids that are slightly soluble in organic solvents.
The 31P.
H} NMR spectra of all the platinum complexes distinctly show the typical platinum satellites which are attributed to 31P-195Ptcoupling, in which the 31P.
H} NMR spectrum exhibits three lines with an intensity ratio of ca.
1:4:1 [Berger et al.
, 1.
The spectroscopic data.
H} chemical shifts and 1JPPt, for complexes 5 - 8, are listed in Table 1.
Complexes 5 and 6 exhibit the signal at 6 and 97.
8 ppm in the 31P NMR spectrum.
These peaks are shifted by ca.
6 and 18 ppm to lower field relative to the signal of the free ligands indicating the PCPt donation of the PtBuCl or PPhCl group.
This effect was also observed for the platinum complexes of the related compounds, tBu2PC2H4PtBu2 [Benn et al.
, 1.
and Ph2PC2H4PPh2 [Baldwin and Fink, 2.
Complexes 7 and 8 have, however, chemical shifts at higher field by ca.
19 and 10 ppm compared with the signals of the free ligands, 117.
and 3 ppm .
, respectively.
This effect reflects the increase in electron density at the phosphorus atoms, which is presumably due to the pA(N)-dA(P) interaction.
This also affects the phosphorus-platinum donor bond as well as the platinum-phosphorus backbonding, which is expected to increase as the electronegativity of the substituents at phosphorus increases [Hill et al.
, 1.
The large 1JPPt values of the complexes .
3 - 4895 H.
indicate the cis coordination of the bidentate phosphine ligands [Berger et al.
Sturm et al.
, 2000.
Gray et al.
, 2.
, as shown also by the X-ray structures, whereas the JPPt values for trans platinum complexes are significantly lower [Berger et al.
, 1996.
Johansson, et al.
, 2.
While the tert-butyl groups in complex 5 cause the smallest P-Pt coupling constant, the diphenylamino groups in complex 8 are responsible for the largest P-Pt coupling In general, the P-Pt coupling constants of the complexes increase with the electronegativity of the substituents on phosphorus, which increases the A-acceptor character of the phosphines [Hill et , 1983.
Grim et al.
, 1.
In the 13C NMR spectra, complexes 7 exhibits the complex coupling patterns of an aoXXAo spin system for the PCCP group, which appears as a pseudo-triplet, in which the coupling constants, 1JPC AA 2JPC, is 25.
2 Hz.
While a more complex pattern is observed for complex 5 due to coupling to the platinum and phosphorus atoms .
JPtC = 102.
6 Hz.
1JPC = 28.
1 H.
Complex 6 is very little soluble in conventional organic solvents, therefore no 13C NMR spectra could be obtained.
Maulana, et al.
, 2010
Indones.
Cancer Chemoprevent.
, 1.
, 1-11
-4567-
Table 1.
H} chemical shifts, 1JPPt of complexes 5-8 and the chemical shift differences between the complexes and the free ligand (Acomplex - Aligan.
H} Complex .
cis-rac-AuPtCl2A1,2-(PtBuC.
2C2B10H10AAy .
1JPPt (H.
iA .
cis-rac-AuPtCl2A1,2-(PPhC.
2C2B10H10AAy .
cis-rac-AuPtCl2A1,2-(P{NEt.
2C2B10H10AAy .
cis-rac-AuPtCl2A1,2-(P{NPh.
2C2B10H10AAy .
Table II.
Selected bond lengths .
I) of 5 and 6 Pt.
-P.
Pt.
-P.
Pt.
-P.
Pt.
-P.
Pt.
-Cl.
Pt.
-Cl.
Pt.
-Cl.
Pt.
-Cl.
Cl.
-P.
Cl.
-P.
Cl.
-P.
Cl.
-P.
-C.
-C.
-C.
-C.
-C.
-C.
-C.
-C.
-C.
-C.
Cl3
Cl4
C12
C10
Cl1 Fig.
Molecular structure of 5 (ORTEP plot with atom labeling scheme, thermal ellipsoids are drawn at the 50 % probability level, hydrogen atoms are omitted for clarity, only one enantiomer is Maulana, et al.
, 2010
Indones.
Cancer Chemoprevent.
, 1.
, 1-11
-4567-
Cl3
Cl4
C13
C14
Cl1
C12
C8 C3
Fig.
C4 C1
C11
Cl2
C10
Molecular structure of 6 (ORTEP plot with atom labeling scheme, thermal ellipsoids are drawn at the 50 % probability level, hydrogen atoms are omitted for clarity, only one enantiomer is show.
Table i.
Selected bond angles .
) for 5 and 6 P.
-Pt.
-P.
-Pt.
-P.
-Pt.
-Cl.
-Pt.
-Cl.
-Pt.
-Cl.
-Pt.
-Cl.
-Pt.
-Cl.
-Pt.
-Cl.
-Pt.
-Cl.
-Pt.
-Cl.
Cl.
-Pt.
-Cl.
Cl.
-Pt.
-Cl.
-P.
-C.
-P.
-C.
-P.
-Cl.
-P.
-Cl.
-P.
-Cl.
-P.
-Cl.
-P.
-Pt.
-P.
-Pt.
-P.
-Pt.
-P.
-Pt.
Cl.
-P.
-Pt.
Cl.
-P.
-Pt.
-P.
-C.
-P.
-C.
-P.
-Cl.
-P.
-Cl.
-P.
-Cl.
-P.
-Cl.
-P.
-Pt.
-P.
-Pt.
-P.
-Pt.
-P.
-Pt.
Cl.
-P.
-Pt.
Cl.
-P.
-Pt.
Maulana, et al.
, 2010
Indones.
Cancer Chemoprevent.
, 1.
, 1-11
-4567Table IV.
Selected bond lengths .
I) and bond angles .
) for 7 Selected bond lengths Pt.
-P.
Pt.
-P.
Pt.
-Cl.
Pt.
-Cl.
Cl.
-P.
Cl.
-P.
-N.
-C.
-N.
-C.
-C.
Selected bond angles P.
-Pt.
-P.
-Pt.
-Cl.
-Pt.
-Cl.
-Pt.
-Cl.
-Pt.
-Cl.
Cl.
-Pt.
-Cl.
-P.
-C.
-P.
-Cl.
-P.
-Cl.
-P.
-Pt.
-P.
-Pt.
Cl.
-P.
-Pt.
-P.
-C.
-P.
-Cl.
-P.
-Cl.
-P.
-Pt.
-P.
-Pt.
Cl.
-P.
-Pt.
Cl3 Cl4 Cl2 Fig.
Cl1
C10
Molecular structure of 7 (ORTEP plot with atom labeling scheme, thermal ellipsoids are drawn at the 50 % probability level, hydrogen atoms are omitted for clarity, only one enantiomer is Maulana, et al.
, 2010
Indones.
Cancer Chemoprevent.
, 1.
, 1-11
-4567-
The carbon atoms of the carbaborane cluster in 7 also show coupling to the platinum atom .
JPtC = 169 H.
, whereas no coupling was observed in other platinum complexes.
The platinum-carbon coupling was observed also for the tert-butyl group of compound 5 .
JPtC = 54 H.
The chemical shift of the carbon atoms of the tert-butyl group in compound 10 is shifted downfield by ca.
10 ppm with respect to that in the free ligand 1 [Sterzik et al.
, 2.
and split into a triplet of pseudotriplets due to coupling with the platinum and phosphorus atoms .
JPC = 40.
1 and JPC = 7.
9 H.
, whereas in the free ligand the coupling constant is smaller .
JPC = 17 H.
Single crystals of 5 and 6 were obtained from a concentrated toluene solution at room Compound 5 crystallizes in the orthorhombic space group Pbca with eight formula units in the unit cell, complex 6 crystallizes in the triclinic space group P 1 with two molecules in the unit cell.
Due to the crystallographic center of inversion, both enantiomers (R,R and S,S) are present in the unit cell of compound 5 and 6 (Fig.
and Fig.
Selected bond lengths and angles of 5 and 6 are reported in Table 2.
Colorless crystals of compounds 7 was obtained from a toluene solution at room Single crystals of 7 crystallizes in the triclinic space group P 1 , in which two molecules of 7 and one molecule of toluene were found in the unit cell of 7.
Selected bond lengths and angles of 7 are collected in Table 4.
The structure of the platinum complexes consists of a slightly distorted square-planar coordination sphere, in which the platinum atom is bonded to two chlorides and two phosphorus atoms of the chelating carbaboranylphosphine.
Thus the platinum atoms exhibit the coordination number four, which is preferred in platinum(II) complexes [Paavola et al.
, 2002.
Hill et al.
, 1983.
Cravotto et al.
, 2005.
Hush et al.
, 2.
The sums of the bond angles of platinum are around 360A.
The carbaboranylphosphine ligands to platinum leads to the formation of a five-membered ring.
As expected, the P.
-Pt-P.
bond angles in the monomer platinum complexes are found 3.
A .
2A .
, which is the preferred P-M-P bite angle for square-planar complexes with two carbon atoms as spacer between the two phosphorus donor atoms [Van Leeuwen et al.
, 2.
According to the Cambridge Crystallographic Data Center (CCDC) the P-Pt-P bond angles for related platinum complexes lie in the range of 82.
4 [Vasconselos et , 1.
1A [Paavola et al.
, 2.
Thus, compound 5 exhibits the largest P-Pt-P bond The Pt-P distances in 7 is 2.
yI, which is in the range of Pt-P bond lengths for related compounds .
182 yI [Claver et al.
, 2.
- 2.
yI [Harada, 1.
The short bond lengths indicate relative strong Pt-P bonds, which can be rationalized by the presence of the orthocarbaborane backbone as well as the electronwithdrawing substituents on the phosphorus atoms.
The Pt-Cl bonds in 5 is 2.
yI, which is in agreement with those observed in related platinum complexes .
395 yI [Dahlenburg and Mertel, 2.
It has been reported previously, that the P-Pt coupling constants reflect the strength of the Pt-P bonds [Hill et al.
, 1.
Therefore, compound 7, which possess the largest 1JPPt coupling constant, display the shortest Pt-P bonds.
This trend is electron-withdrawing substituents on the phosphorus atoms increase the dACdA interaction between the platinum and the phosphorus donor atoms [Grim et al.
, 1.
the other hand, this so-called backbonding would also increase the A-bond character of the Pt-P bond by a synergistic effect [Grim et al.
, 1.
The backbonding effect is also revealed by the 31P NMR spectrum, in which the signals of the platinum complexes 7 - 8 are shifted to higher field relative to those of the free ligands.
The C-C distances of the carbaborane cage were found to decrease on complexation to Compound 5 provides the largest decrease in C-C distance for the mononuclear platinum complexes, i.
062 yI relative to that of the free ligand 1 .
770 yI) [Sterzik et al.
, 2.
The diminution of C-C distances can be rationalized by the change of electronic properties of the phosphorus atoms due to complexation.
It was observed that major elongation of the C-C bond is obtained when the element with the lone pair of electrons is directly connected with the The electron density from the available lone pair of electrons of the element is transferred to the cage, producing an increase in the C-C distance [Teixidor et al.
, 2.
The electron density on the phosphorus atoms in 5 is lower due to the strong A (PCP.
donor character of the PtBuCl group, resulting in a larger decrease in C-C bond length relative to the free ligand.
A decrease in P-Ccluster bond lengths is also observed for the the platinum complexes, which is probably due to the change in electron density of the phosphorus atoms during the complexation.
Compound 6 shows the largest decrease in the P8 Maulana, et al.
, 2010
Indones.
Cancer Chemoprevent.
, 1.
, 1-11
-4567-
Ccluster distance of the mononuclear platinum complexes, which indicates a higher electron density on the phosphorus atoms.
CONCLUSION
Compounds 1, 2, 3, and 4 show the capability to act as ligands in complexation reactions with platinum metal.
The platinum complexes cis-rac-AuPtCl2A1,2-(PRC.
2C2B10H10AAy (R = tBu .
Ph .
NEt2 .
NPh2 .
were obtained from the reaction of [PtCl2(COD)] with the corresponding chiral carbaboranylphosphine ligand 1 Ae 4.
The complexes mentioned above were fully characterized by NMR.
IR, and MS, and, other than 14 and 22, also by X-ray
ACKNOWLEDGMENT
We gratefully acknowledge support from the Deutscher Akademischer Austausch Dienst (DAAD doctoral grant for I.
REFERENCES